Mode
Text Size
Log in / Sign up
N/A N=291 Randomized Double-blind Treatment

Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation

Overweight and Obesity

Enrolled (actual)
291
Serious AEs
30.6%
Results posted
Jul 2025
Primary outcome: Primary: Change in Weight Loss in Kilograms (kg) — -1.8; -0.3; -3.4; -0.2 kg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ACHIEVE Intervention (Behavioral); Control (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Johns Hopkins University
Primary completion
Sep 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Weight Loss in Kilograms (kg)
-1.8; -0.3; -3.4; -0.2
SECONDARY
Minutes Cycled During Cycle Ergometry Testing
6.95; 6.86; 7.12; 6.91; 7.19; 6.79
SECONDARY
Change in Waist Circumference in Centimeters (cm)
-1.5; 0.5; -2.2; -1.9
SECONDARY
Change in Systolic and Diastolic Blood Pressure (mmHg)
-2.5; -2.1; -0.7; -0.9; -1.1; -2.7
SECONDARY
Change in Lipids (Total Cholesterol, LDL, HDL and Triglyceride (mg/dL)
-4.8; -1.9; -5.6; -0.3; -3.8; -2.5
SECONDARY
Framingham Cardiovascular Risk Score
0.0999; 0.0989; 0.1029; 0.0991; 0.1035; 0.0978
SECONDARY
Health Status as Measured by the SF-12
45.1; 43.4; 45.5; 43.8; 46.2; 44.4
SECONDARY
Depression Assessed by Center for Epidemiologic Studies Depression Scale (CES-D)
19.7; 20.1; 18.7; 20.9; 18.7; 19.5

Summary

This study will determine whether a behavioral weight loss intervention including dietary counseling and exercise is effective in helping people with serious mental illnesses lose weight.

Eligibility Criteria

Age 18 and older;

  • Overweight, defined by Body Mass Index at least 25.0 kg/m2;
  • Able and willing to give informed consent and participate in the intervention;
  • On the same psychiatric medications within the 30 days before baseline weight (dose changes allowed;)
  • Able to attend at least 2 intervention sessions per week during initial 6-month phase;

Exclusion criteria

  • Contraindication to weight loss
  • Receiving active cancer treatment (radiation/chemotherapy)
  • Liver failure
  • History of anorexia nervosa;
  • Cardiovascular event (unstable angina, myocardial infarction) within previous 6 months;
  • Prior or planned bariatric surgery;

Use of prescription weight loss medication or over-the-counter orlistat within 3 months

if participant does not agree to stop taking it;

  • Twenty pound or greater weight loss in 3 months prior to baseline, as documented by staff measurement;
  • Inability to walk to participate in exercise class;
  • Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician;
  • Alcohol or substance use disorder either: 1) active and determined to be incompatible with participation in the intervention through discussion with program staff; or 2) new abstinence from alcohol or substance use disorder in past 30 days;
  • Planning to leave rehabilitation center within 6 months or move out of geographic area within 18 months;
  • Investigator judgment (e.g., for concerns over safety, adherence or follow-up);
  • Weight greater than 400 pounds.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00902694). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search